Lexaria Bioscience (LEXX) Operating Leases (2020 - 2025)
Historic Operating Leases for Lexaria Bioscience (LEXX) over the last 5 years, with Q4 2025 value amounting to $101920.0.
- Lexaria Bioscience's Operating Leases changed 0.0% to $101920.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $101920.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $109319.0 for FY2025, which is 2041.77% down from last year.
- Per Lexaria Bioscience's latest filing, its Operating Leases stood at $101920.0 for Q4 2025, which was down 0.0% from $109319.0 recorded in Q3 2025.
- Lexaria Bioscience's 5-year Operating Leases high stood at $137366.0 for Q3 2024, and its period low was $18339.0 during Q2 2022.
- Moreover, its 4-year median value for Operating Leases was $101920.0 (2024), whereas its average is $90420.7.
- Its Operating Leases has fluctuated over the past 5 years, first crashed by 8140.98% in 2022, then changed by 0.0% in 2025.
- Quarter analysis of 4 years shows Lexaria Bioscience's Operating Leases stood at $49989.0 in 2021, then tumbled by 63.31% to $18339.0 in 2022, then surged by 455.76% to $101920.0 in 2024, then changed by 0.0% to $101920.0 in 2025.
- Its Operating Leases stands at $101920.0 for Q4 2025, versus $109319.0 for Q3 2025 and $116586.0 for Q2 2025.